It turned out to be a mistake that cost almost $7bn. When Celgene’s chief executive, , announced his company was buying Receptos, a Californian biotech, for $7.2bn earlier this month, his jubilation must have been tempered by the knowledge that he
Gilead Sciences is an American pharmaceutical company driven by unquenchable greed. The company is causing hundreds of thousands of Americans with Hepatitis C to suffer unnecessarily and many of them to die as the result of its monopolistic practices, while public health programs face bankruptcy.
Teva Pharmaceutical, the Israeli drugmaker, is nearing a deal to acquire Allergan’s generics drug unit for between $40bn and $45bn, according to people familiar with the matter. A deal, which one person said could be announced within days, would be
I find it remarkable that the industry pushes us so hard to use these patient portals, since they offer so little of value to meeting our health needs. With more portals launching every week, and an estimated $900 million spent on them annually by 2017, more and more “patients” will be asking themselves the question, “What am I supposed to do with this?”
Who carries more weight with patients: celebrities, models or real people? What one change would influential patients make to pharma's advertising? WEGO Health tried to get some answers from high-profile patients.
Richard Meyer's insight:
In a study focusing on "patient influencers"--those who lead disease groups or online awareness sites, among others--WEGO focused mainly on ways drugmakers can or should develop relationships with patients. But as Medical Marketing & Media reports, the respondents also sounded off on DTC advertising and promotions.
Anthem is close to acquiring Cigna for more than $48bn, in what would be the second health-insurance deal to be spurred as a direct reaction to Obamacare. Anthem would value Cigna at $187 per share, said people involved in the negotiations. However,
Pharma companies need to put themselves in the patient's shoes and provide clear, helpful content at what is often a worrying and stressful time. Richard Meyer offers some useful pointers. In recent market research, an oncologist said that, when...
It is just over a year since Brent Saunders became chief executive of Allergan, then known as Actavis, but he has changed the company beyond recognition. First up was his acquisition of Botox owner Allergan for $70bn last year, and the adoption of
News that Anthem (ANTM) will buy Cigna (CI) for $54 billion-- a deal that closely follows the proposed merger of Aetna (AET) and Humana (HUM) -- will intensify regulators’ focus on antitrust issues in the health insurance industry. Because Anthem’s proposed acquisition of Cigna creates the nation’s largest health insurer with [...]
Shire, the UK-listed drugmaker, still sees opportunities for growth-boosting acquisitions despite the surge in valuations in the sector, according to its chief executive. Flemming Ornskov said the group continued to hunt for deals — big and small —
Dozens of big investors have backed a campaign by British activists for more transparency in the pharmaceuticals industry. BNP Paribas and Aviva Investors are among 85 pension funds and asset managers from Europe, the US and Australia urging
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.